Helicobacter pylori and Clarithromycin Resistance, PCR, Miscellaneous

Test Code
20400


CPT Codes
87513

Preferred Specimen
5 mL of liquid or soft stool collected Cary-Blair transport medium or
3 mm fresh tissue collected in a sterile plastic container


Minimum Volume
5 mL liquid or soft stool • 3 mm fresh tissue • 1 bacterial isolate


Other Acceptable Specimens
1 bacterial isolate submitted on H. pylori growth media


Instructions
Stool: Avoid contamination of stool specimen with urine or water. Specimens are best collected in a bedpan or a clean dry container. A suitable area (i.e., bloody, slimy, watery) from the sides, ends and middle of the stool should be selected using the collection spoon provided. Fill with sufficient stool to bring the liquid level up to the "Fill" line. This will result in approximately 5 mL of sample. Stir each specimen with the spoon provided, tighten the cap and shake firmly until the specimen is adequately mixed. When mixing is complete, the specimen should appear uniform. Complete the label on the vial and place the vial in the plastic bag. Transport the specimen to the laboratory.

Tissue: Place tissue in sterile plastic container

Bacterial isolate: Bacterial isolate grown in pure culture can be submitted with H. pylori growth media. Do not submit mixed cultures.


Transport Temperature
Room temperature


Specimen Stability

Stool
Room temperature: 30 days
Refrigerated: 30 days
Frozen: Unacceptable

Tissue and bacterial isolate
Room temperature: 14 days
Refrigerated: 30 days
Frozen: 30 days



Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Unpreserved (raw) stool at any temperature • Stool in non-Cary-Blair stool culture transport medium • Frozen specimens in Cary-Blair stool culture transport medium • Mixed isolates • Containers that are cracked, broken or leaking


Methodology
Real-Time Polymerase Chain Reaction

Reference Range
See Laboratory Report


Clinical Significance
This assay is used to detect the presence of Helicobacter pylori as well as genetic markers of resistance to the antibiotic clarithromycin. The assay targets the most common single nucleotide variations (A2143G, A2142G, and A2142C) in the 23S ribosomal RNA gene known to confer resistance to clarithromycin.

H. pylori infection is a major cause of dyspepsia, chronic gastritis, peptic ulcer disease, and gastric cancer, with an estimated prevalence in North America of 30-40% [1]. Treatment focuses on eradication in patients with signs and symptoms consistent with infection as outlined in the American College of Gastroenterology (ACG) guidelines [1]. These can include non-antimicrobials (eg, bismuth quadruple therapy, proton pump inhibitors) as well as antibiotics such as clarithromycin, amoxicillin, rifabutin, tetracycline and metronidazole. Clarithromycin has been the standard treatment for many years, but resistance is increasing and resistance guided therapy is recommended [2].

This assay utilizes a nucleic acid amplification method. Results should be correlated with other clinical findings as low levels of H. pylori nucleic acid in a specimen may yield a "not detected" result for clarithromycin genetic markers.

References:
1. Chey WD, Howden CW, Moss SF, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2024;119(9):1730-1753. doi:10.14309/ajg.0000000000002968
2. Schuetz AN, Theel ES, Cole NC, Rothstein TE, Gordy GG, Patel R. Testing for Helicobacter pylori in an era of antimicrobial resistance. J Clin Microbiol. 2024;62(2):e0073223. doi:10.1128/jcm.00732-23




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.